While cell-based therapies offer huge potential, significant challenges, including GMP manufacturing, scaling-out, and delivery must be addressed and overcome in order to justify and successfully autologous and allogeneic provides to the market.
Speaker:
Susan McKee, Business Development Manager, Angel Biotechnology

Listen to the audio cast here

[sc_embed_player_template1 fileurl=”http://commondatastorage.googleapis.com/bpidm/Tackling-the-Challenges-in-the-Manufacturing-of-Cell-Based-Therapies.mp3″]